Assessment of the effectiveness of sympathetic nervous system inhibitation through various therapeutic regimes on nictemeral variability of blood pressure and circadian profile in patients with resistant hypertension

Authors

  • CARAUSH Alexandr IMSP Institutul de Cardiologie, Clinica ,,Hipertensiuni arteriale”
  • MOISEEVA Anna IMSP Institutul de Cardiologie, Clinica ,,Hipertensiuni arteriale”
  • COCIU Maria IMSP Institutul de Cardiologie, Clinica ,,Hipertensiuni arteriale”

DOI:

https://doi.org/10.52692/1857-0011.2022.1-72.06

Keywords:

denervation of renal arteries, resistant hypertension

Abstract

Despite administration of various drug treatment regimens leaves a large proportion of patients with resistant hyperten- sion with uncontrolled blood pressure values, who are at increased risk for cardiovascular and renal complications. Recognition of the major role of the sympathetic nervous system in the pathogenesis of hypertension has led to the development of new minimally invasive methods, which reduce the activity of the sympathetic nervous system at the peripheral renal level, resulting in reduced blood pressure. One such treatment is renal artery denervation - an innovative method devised 10 years ago that involves disrupting afferent and efferent renal sympathetic fibers by applying radiofrequency energy.In this way, we aimed to conduct an open-label clinical study that will assess the effectiveness of blocking the sympathetic nervous system through various therapeutic regimens on blood pressure variability and diurnal profile in patients with resistant hypertension. The data obtained demonstrated the antihypertensive effectiveness of both pharmacological and interventional treatment, but renal denervation having a much higher impact.

Author Biographies

CARAUSH Alexandr, IMSP Institutul de Cardiologie, Clinica ,,Hipertensiuni arteriale”

dr. hab. șt. med., profesor cercetător

MOISEEVA Anna, IMSP Institutul de Cardiologie, Clinica ,,Hipertensiuni arteriale”

dr. șt. med., cercetător științific

COCIU Maria, IMSP Institutul de Cardiologie, Clinica ,,Hipertensiuni arteriale”

cercetător științific

References

Vardas P., Maniadakis N., Bardinet I. et al., The European Society of Cardiology Atlas of Cardiology: rational, objectives, and methods. European Heart Journal Quality of Care and Clinical Outcomes., 2016; vol. 2(1), pp. 6-15. ISSN: 2058-1742.

Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J., Global burden of hypertension: analysis of worldwide data. Lancet., 2005; 365, p. 217–223.

Egan B.M., Zhao Y., Axon R.N., US trends in prevalence, awareness, treatment and control of hypertension,1988-2008. JAMA., 2010; 303, p. 2043–2050.

Lewington S., Clarke R., Qizilbash N., Peto R., Collins R., Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet., 2002; 360, p. 1903–1913.

Turnbull F., Neal B., Ninomiya T., et al., Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ., 2008; 336, p. 1121–1123.

Krum H., et al., Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet., 2009; 373, p. 1275–1281.

Published

2022-04-08